The DART Study: Part 1 results from the dalantercept plus axitinib dose escalation and expansion cohorts in patients with advanced renal cell carcinoma (RCC) Meeting Abstract


Authors: Voss, M. H.; Plimack, E.; Rini, B.; Alter, R.; Bhatt, R. S.; Beck, J. T.; Mutyaba, M.; Pappas, K.; Wilson, D.; Zhang, X.; Sun, J.; Glasser, C.; Sherman, M. L.; Pandya, S. S.; Atkins, M. B.
Abstract Title: The DART Study: Part 1 results from the dalantercept plus axitinib dose escalation and expansion cohorts in patients with advanced renal cell carcinoma (RCC)
Meeting Title: 14th International Kidney Cancer Symposium (IKCS)
Journal Title: BJU International
Volume: 116
Issue: Suppl. 5
Meeting Dates: 2015 Nov 6-7
Meeting Location: Miami, FL
ISSN: 1464-4096
Publisher: Wiley Blackwell  
Date Published: 2015-12-01
Start Page: 22
Language: English
ACCESSION: WOS:000366284900044
PROVIDER: wos
PUBMED: 26492557
DOI: 10.1111/bju.13365
Notes: Meeting Abstract -- 14th International Kidney Cancer Symposium -- NOV 06-07, 2015 -- Miami, FL -- SI -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Martin Henner Voss
    288 Voss